Elucidating the Role of Cutaneous Environmental Factors in the Development of Allergic Disease
Project Number5K08AI171182-02
Former Number1K08AI171182-01
Contact PI/Project LeaderEISENSTEIN, ANNA
Awardee OrganizationYALE UNIVERSITY
Description
Abstract Text
Project Summary/Abstract
This proposal describes a rigorous training program leading to the career development of Dr. Anna Eisenstein
as an independent scientist. The principal investigator is a physician scientist who recently completed
Dermatology residency. Her career goal is to become an independent investigator studying the interplay between
the skin barrier and immune function, with a particular interest in allergic disease. She proposes to expand her
training in immunology and allergy through an intensive research experience under the co-mentorship of Dr.
Andrew Wang and Dr. Joseph Craft as well as a preeminent advisory committee with leading scientists and
physician scientists in immunology and dermatology. In addition to excellent mentoring, the proposal includes
rigorous coursework, seminars and external meetings. These planned activities will equip her with the necessary
skills to become a successful independent investigator.
The research objective of this proposal is to understand why individuals with atopic dermatitis (eczema) are more
prone to food allergies, both conditions whose prevalence are exponentially rising. Preliminary data reveals that
environmental xenobiotics, like common over-the-counter medications and food preservatives, act as allergic
adjuvants both when given orally or applied topically. These products were all found to activate the xenobiotic
receptor, Nuclear factor erythroid 2-related factor (Nrf2). Cutaneous disruption or topical application of Nrf2
activators was sufficient to induce sensitization to orally introduced food antigens, suggesting a novel mechanism
of sensitization, distinct from the current epicutaneous paradigm wherein food allergens are thought to physically
contact a damaged skin barrier to program the allergic immune response. The proposal will test the hypothesis
that disruption of the skin barrier and/or topical chemical adjuvants that activate Nrf2 in keratinocytes promote
epidermal production of alarmins, which signal on the intestinal epithelium and gut resident dendritic cells to
initiate allergic sensitization to coincident non-tolerized oral allergens in a skin-gut-immune axis using a unique
collection of full body and conditional knock out mice.
This proposal serves as a training vehicle for Dr. Eisenstein to become an expert in immunobiology, mechanisms
of allergic sensitization, and cutaneous barrier function so that she can apply this expertise to the field of
dermatology and harmonize her clinical and research programs for maximal impact in translating her basic
science investigations to the clinical management of atopic diseases. This project has the potential to explain
the modern rise in incidence of food allergies as well as the clinical association between eczema and food
allergies, which could lead to significant influence on public health and lead to novel therapeutic approaches to
food allergy. Furthermore, these results may yield important novel insights into our fundamental understanding
of the mechanisms of allergic sensitization.
Public Health Relevance Statement
Project Narrative
Food allergy is increasing in prevalence in industrialized nations and is often associated with eczema. We will
identify cutaneous factors that promote the development of food allergies and determine the mechanism(s) for
this effect. Elucidation of mediators of food allergy will have a significant public health benefit in the reduction of
the burden of disease.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
043207562
UEI
FL6GV84CKN57
Project Start Date
01-July-2023
Project End Date
30-June-2028
Budget Start Date
01-July-2024
Budget End Date
30-June-2025
Project Funding Information for 2024
Total Funding
$194,940
Direct Costs
$180,500
Indirect Costs
$14,440
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Allergy and Infectious Diseases
$194,940
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5K08AI171182-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5K08AI171182-02
Patents
No Patents information available for 5K08AI171182-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5K08AI171182-02
Clinical Studies
No Clinical Studies information available for 5K08AI171182-02
News and More
Related News Releases
No news release information available for 5K08AI171182-02
History
No Historical information available for 5K08AI171182-02
Similar Projects
No Similar Projects information available for 5K08AI171182-02